Watch OCUL. Know when insiders buy.
One email the day a filing lands. Free.
OCUL
OCULAR THERAPEUTIX, INC
6.48
−0.17 −2.56%
USD · close Oct 21
A free account adds a watchlist, alerts when insiders, Congress or short sellers move on your tickers, and a morning brief. Sign up
Work order
42
WATCH · insiders 30, shorts 54
Insiders, 90 days
−$568K
net selling · 0 buys, 8 sells
Congress, 90 days
0 / 0
no disclosures naming it
Big money
0 / 15
none of the tracked funds disclose it
Calls on record
0
nobody we score has called it yet
MKT CAP $1.4BP/E —DIV YIELD —FCF YIELD -17.93%REV TTM $52.1M −8.1%NET INCOME −$301.4MNET CASH $580.6M52W 6.29 – 16.11SEC XBRL · TTM TO Invalid Date
Insider trading
−$568K
Net, 90 days
0 / 8
Buys / sells, 90 days
0
Distinct buyers
$0
Bought, 90 days
| Traded | Filed | Insider | Type | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Oct 8 | Oct 13 | Anderman Todd · Chief Legal Officer | Sell | 11,984 | $7.29 | $87K |
| Oct 2 | Oct 6 | Kaiser Peter · Chief Development Officer | Sell | 9,990 | $7.05 | $70K |
| Oct 2 | Oct 6 | Heier Jeffrey S. · Chief Scientific Officer | Sell | 10,869 | $7.05 | $77K |
| Aug 31 | Sep 2 | Notman Donald · Chief Operating Officer | Sell | 1,099 | $10.24 | $11K |
| Aug 24 | Aug 26 | Nayak Sanjay · Chief Strategy Officer | Sell | 1,897 | $10.78 | $20K |
| Aug 24 | Aug 26 | Kaiser Peter · Chief Development Officer | Sell | 3,035 | $10.77 | $33K |
| Aug 24 | Aug 26 | Heier Jeffrey S. · Chief Scientific Officer | Sell | 3,296 | $10.78 | $36K |
| Aug 24 | Aug 26 | Dugel Pravin · See Remarks | Sell | 21,649 | $10.77 | $233K |
Source: SEC EDGAR Form 4 filings, pulled nightly; open-market purchases and sales only, no option exercises or grants. The tracker, all tickers.